BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19360404)

  • 1. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging.
    Liu Z; Niu G; Wang F; Chen X
    Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, preclinical, and initial clinical evaluation of integrin α
    Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin α
    Liu K; Jiang T; Rao W; Chen B; Yin X; Xu P; Hu S
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1544-1557. PubMed ID: 38276986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin α
    Li H; Peng W; Zhen Z; Zhang W; Liao S; Wu X; Wang L; Xuan A; Gao Y; Xu J
    Nucl Med Biol; 2023; 124-125():108364. PubMed ID: 37591041
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Rinne SS; Abouzayed A; Gagnon K; Tolmachev V; Orlova A
    Sci Rep; 2021 Feb; 11(1):3631. PubMed ID: 33574368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of [
    Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of
    Liu Q; Cai S; Ye J; Xie Q; Liu R; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1826-1840. PubMed ID: 38319321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Preclinical Evaluation of
    Makris G; Bandari RP; Kuchuk M; Jurisson SS; Smith CJ; Hennkens HM
    Mol Imaging Biol; 2021 Feb; 23(1):52-61. PubMed ID: 32886303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.
    Liu Y; Hu X; Liu H; Bu L; Ma X; Cheng K; Li J; Tian M; Zhang H; Cheng Z
    J Nucl Med; 2013 Dec; 54(12):2132-8. PubMed ID: 24198391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiometal Complexes as Pharmacokinetic Modifiers: A Potent
    Schreck MV; Burgard C; Schmidtke A; Hierlmeier I; Stemler T; Maus S; Rosar F; Jung M; Speicher A; Ezziddin S; Holland JP; Bartholomä MD
    Mol Pharm; 2023 Dec; 20(12):6463-6473. PubMed ID: 37978936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched-pair,
    Bandara N; Stott Reynolds TJ; Schehr R; Bandari RP; Diebolder PJ; Krieger S; Xu J; Miao Y; Rogers BE; Smith CJ
    Nucl Med Biol; 2018; 62-63():71-77. PubMed ID: 29929115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a dual-receptor targeted tracer [
    Lv X; Song X; Long Y; Zeng D; Lan X; Gai Y
    Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):54-67. PubMed ID: 37642706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Succinimidyl 4-[(18)F]-fluoromethylbenzoate-labeled dimeric RGD peptide for imaging tumor integrin expression.
    Li W; Lang L; Niu G; Guo N; Ma Y; Kiesewetter DO; Shen B; Chen X
    Amino Acids; 2012 Sep; 43(3):1349-57. PubMed ID: 22209865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of fluorine-labeled gastrin-releasing peptide receptor (GRPR) agonists and antagonists by LC/MS.
    Ma Y; Yang M; Gao H; Niu G; Yan Y; Lang L; Kiesewetter DO; Chen X
    Amino Acids; 2012 Oct; 43(4):1625-32. PubMed ID: 22354143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.
    Ghosh A; Raju N; Tweedle M; Kumar K
    Cancer Biother Radiopharm; 2017 Feb; 32(1):24-32. PubMed ID: 28186846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of α
    Imberti C; Terry SY; Cullinane C; Clarke F; Cornish GH; Ramakrishnan NK; Roselt P; Cope AP; Hicks RJ; Blower PJ; Ma MT
    Bioconjug Chem; 2017 Feb; 28(2):481-495. PubMed ID: 27966893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours.
    Chilug LE; Niculae D; Leonte RA; Nan A; Turcu R; Mustaciosu C; Serban RM; Lavric V; Manda G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of [64Cu]Cu-NODAGA-RGD-BBN as a Novel Radiotracer for Dual Integrin and GRPR-targeted Tumor PET Imaging.
    Amraee N; Alirezaour B; Hosntalab M; Hadadi A; Yousefnia H
    Curr Radiopharm; 2024 Feb; ():. PubMed ID: 38409731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Myocardial α
    Nammas W; Paunonen C; Teuho J; Siekkinen R; Luoto P; Käkelä M; Hietanen A; Viljanen T; Dietz M; Prior JO; Li XG; Roivainen A; Knuuti J; Saraste A
    J Nucl Med; 2024 Jan; 65(1):132-138. PubMed ID: 37973184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.